Daniel J. Medici
About Daniel J. Medici
Appointed to Hanmi Financial Corporation’s Board effective October 1, 2025; serves on the Audit Committee and the Risk, Compliance and Planning (RCP) Committee for the Company, and the Loan and Credit Policy (LCP) Committee at Hanmi Bank . Career regulator with 36+ years at the Office of the Comptroller of the Currency (OCC), most recently Senior Bank Information Technology Lead Expert Risk Specialist (May 2020–Feb 2025); expertise in IT, cybersecurity, and operational risk for large financial institutions . Education: B.A. in Finance and M.S. in Management Science/Statistics, both from California State University, Fullerton; certifications include CISSP, CISA, CCSP, CRISC, and CompTIA Network+/A+ . Newly appointed independent director (assigned to Audit and RCP; no related-party transactions under Item 404(a)); initial Form 3 reported no beneficial ownership at appointment .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Office of the Comptroller of the Currency (OCC) | Senior Bank Information Technology Lead Expert Risk Specialist | May 2020–Feb 2025 | IT/cybersecurity risk oversight for large financial institutions and service/fintech providers; senior risk specialist experience |
| Office of the Comptroller of the Currency (OCC) | Various examiner and IT-focused roles | 36+ years; retired Feb 2025 | Emphasis on bank information technology; recognized expert in IT, cybersecurity, and operational processes |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| — | — | — | No other public company directorships disclosed in the appointment 8-K/press release |
Board Governance
- Committee assignments (current): Audit (member); RCP (member); Loan and Credit Policy Committee at Hanmi Bank (member) .
- Independence and conflicts: Company disclosed no relationships requiring Item 404(a) related‑party disclosure for Medici; appointed directly to Audit and RCP (committees populated by independent directors under Nasdaq rules) .
- Attendance and engagement: 2024 proxy reports all directors attended >75% of Board/committee meetings; Medici joined in October 2025, so 2024 attendance data precede his tenure .
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Annual Board cash retainer | $42,500 | Standard non‑employee director retainer |
| Audit Committee membership retainer | $6,000 | Annual cash retainer for committee members |
| RCP Committee membership retainer | $5,000 | Annual cash retainer for committee members |
| LCP Committee (Bank) membership retainer | $5,000 | Annual cash retainer for LCP members |
| Chairman/Vice Chairman adders | $40,000 / $20,000 | Only if serving in these roles (not applicable to Medici per appointment) |
| Indicative annual cash (sum of Board + listed committees) | $58,500 | Eligible amounts based on current assignments; first‑year payments typically pro‑rated from appointment date |
Performance Compensation
| Element | Typical Timing | Quantum/Structure | Vesting | Notes |
|---|---|---|---|---|
| Annual restricted stock grant (non‑employee directors) | Q2 each year | Policy value $65,000 (2024 level) | 1‑year cliff vest | 2024 grant example: 4,040 shares per director at $16.09 ($65,004) |
There are no performance-conditioned (metric-based) equity awards for directors; the annual grant is time-based restricted stock per policy .
Other Directorships & Interlocks
| Company | Role | Committee Roles | Interlocks/Notes |
|---|---|---|---|
| — | — | — | No other public company boards disclosed in the appointment filings |
Expertise & Qualifications
- IT/cybersecurity/operational risk expert; extensive oversight of complex FI and service provider technology environments .
- Degrees: B.A. Finance; M.S. Management Science/Statistics (California State University, Fullerton) .
- Certifications: CISSP, CISA, CCSP, CRISC, CompTIA Network+ and A+ .
- Regulatory background (36+ years at OCC) aligns with Audit/RCP committee oversight needs .
Equity Ownership
| Item | Detail |
|---|---|
| Initial Form 3 (filed) | 10/06/2025; event date 09/24/2025; relationship: Director; no securities beneficially owned |
| Director ownership guidelines | Must acquire Company stock equal to 3x annual retainer within 5 years of joining the Board |
| Hedging/pledging policy | Hedging, short sales, share lending, and pledging Company securities are prohibited |
Governance Assessment
-
Strengths:
- Immediate placement on Audit and RCP underscores Board’s use of his domain expertise (IT/cyber risk and ERM), enhancing oversight of financial reporting, controls, cyber, and enterprise risks .
- No related-party transactions required to be disclosed; reduces conflict risk .
- Strong credentials (CISSP/CISA/CCSP/CRISC) and regulator tenure directly support cyber and operational risk governance .
- Director equity ownership guidelines (3x retainer/5 years) and anti‑hedging/pledging policy support alignment and risk mitigation .
-
Watch items / potential red flags:
- Alignment ramp: Form 3 showed zero initial beneficial ownership at appointment; expect ownership to build via annual restricted stock grants and open‑market purchases to meet 3x guideline within 5 years .
- Attendance and engagement data specific to Medici will first appear in the 2026 proxy; monitor to confirm full participation in Audit/RCP/LCP workloads .
Overall signal: Appointment adds specialized IT/cyber risk oversight to key board committees without evident conflicts; equity alignment should increase as policy‑driven grants accrue and guideline compliance milestones approach .